Skin of Color Update faculty member Maryanne Makredes Senna, MD, FAAD, published research in the Journal of Drugs in Dermatology on the efficacy of low-dose spironolactone for hair loss in women.
Dr. Makredes Senna and her colleagues conducted a retrospective chart review of adult women with female pattern hair loss who were treated with 50 mg or less daily of spironolactone either alone or in combination with other therapies. Results showed a statistically significant decline in the average Sinclair Score in patients treated with spironolactone as monotherapy (2.63 to 1.95) after one year. Including patients on other therapies, such as such as topical minoxidil 5% foam or low-level light laser treatment, results also showed a significant decrease (2.47 to 1.81) after one year.
Attend Dr. Makredes Senna’s hair loss sessions at Skin of Color Update for the latest in treatments for scarring and non-scarring alopecias. Register today!
